Bravecto Spot-On Cat Blue 2.8 – 6.25kg 250mg

Bravecto Spot-On Cat Blue 2.8 – 6.25kg 250mg

Description:

Product description

Specially formulated for medium size cats 2.8 kg to 6.25 kg, this single dose flea & tick treatment for cats, is effective for up to 3 months against paralysis ticks & fleas. Within 12 hours of application, Bravecto spot-on treatment kills adult fleas. This treatment kills newly emerged fleas before they lay eggs, breaks the flea lifecycle, controls recurring flea infestation and also controls flea populations in surrounding areas of the treated cats. Furthermore, this spot-on treatment by Bravecto is also useful in the treatment of flea allergy dermatitis.

Bravecto Spot-On contains fluralaner, which is a potent insecticide and acaricide. These ingredients inhibit part of the arthropod nervous system by destroying certain receptors, leading to the parasites’ elimination. Safe to use on kittens above 11 weeks of age and over 1.2 kg.

Features of Bravecto Spot-on

• Effective against adult fleas and ticks for 3 months
• Treats and controls existing flea and tick infestations & provides continuous protection against fleas and ticks
• Breaks flea life cycle
• Assist in controlling flea allergy dermatitis
• Highly effective against Fipronil resistant fleas

Usage directions

Remove the pipette from the pack, break open the seal for application. Your cat should be in a standing position.

Place the pipette tip on the base of the cat’s head, squeeze the pipette gently and apply the entire content directly to the cat’s skin. Do not the touch the treated area until dry

Ingredients

Fluralaner

Warnings

Keep out of reach of children and pets.  Store at or below 30°C.The product is highly inflammable, keep away from heat, sparks, open flame or other sources of ignition. Wear gloves while applying the product.  Avoid contact with the eyes of the cat. Wash hands immediately after use. Do not allow your cat to lick the treated area. Do not use the product directly on the skin lesions. Do not use in case hypersensitivity to the active substance